Key Focus:
PRECISION MEDICINE
Transforming Treatment Through Genomic Insight
Precision medicine is reshaping healthcare by aligning treatment decisions with the unique genetic makeup of each patient. At its core lies pharmacogenomics (PGx)—the study of how genetic variation influences drug metabolism, efficacy, and toxicity. Together, they’re redefining what it means to deliver personalized care.
At AUGenomics, we empower clinicians, researchers, and biotech teams to uncover the genomic drivers of individual response to therapy. Using next-generation sequencing (NGS), transcriptomics, and integrative bioinformatics, we help you discover, validate, and apply genomic biomarkers that optimize treatment decisions and accelerate therapeutic development.
01
Identify genetic variants that predict therapeutic response or toxicity
02
Validate companion diagnostic biomarkers for clinical trials
03
Profile gene expression to uncover drug resistance mechanisms
04
Stratify patients for personalized treatment plans
05
Correlate genomic data with pharmacokinetic and pharmacodynamic results
06
Develope multi-omic signatures for precision oncology or rare disease treatment
Why Genomics Is Central to Precision Medicine
Every person’s genome holds the key to how they respond to treatment. Variants in drug metabolism genes (like CYP2C19, CYP2D6, TPMT, and DPYD) or in target pathways can profoundly influence dosage, efficacy, and adverse reactions.
Genomic sequencing provides the resolution needed to:
-
Identify pharmacogenomic variants influencing drug metabolism and transport
-
Predict drug response and adverse effects across patient populations
-
Stratify patients for targeted therapies in oncology, cardiology, psychiatry, and more
-
Discover novel biomarkers that guide dose optimization and clinical trial design
-
Integrate genomic, transcriptomic, and environmental data for comprehensive precision medicine models
At AUGenomics, our sequencing workflows are designed for accuracy, reproducibility, and regulatory readiness—bridging the gap between discovery research and clinical implementation. We combine WGS, targeted PGx panels, and transcriptomic profiling with AI-enhanced variant interpretation to deliver actionable insights that drive therapeutic innovation.
Common
Sample Types
We support all major sample types used in pharmacogenomics and precision medicine research:
-
Whole blood / saliva / buccal swabs — for germline pharmacogenomic variant analysis
-
cfDNA / cfRNA (plasma, serum) — for monitoring dynamic treatment response
-
Tumor tissue / FFPE samples — for somatic variant analysis and companion diagnostics
-
Fresh-frozen or cultured cells — for transcriptomic and functional studies
-
Organoids / patient-derived xenografts (PDX) — for drug screening and sensitivity testing
-
Urine or plasma metabolites — for integrated pharmacometabolomic studies
Tailored Services
AUGenomics partners with research, clinical, and translational teams working to personalize medicine at scale.
-
Pharmacogenomic Variant Analysis: Identify SNPs, indels, and CNVs in key drug metabolism and response genes.
-
Targeted NGS Panels: Custom PGx panels covering actionable pharmacogenes for research or validation studies.
-
Whole Genome & Exome Sequencing: Comprehensive variant detection for rare or complex pharmacogenomic traits.
-
Transcriptomics & RNA-seq: Assess gene expression patterns driving drug efficacy or resistance.
-
Companion Diagnostics Development: Integrate biomarker discovery with assay design for clinical use.
-
Multi-omic Data Integration: Combine genomic, transcriptomic, and metabolomic data for predictive modeling.
Explore our sequencing solutions for Precision Medicine & Pharmacogenomics:
Whole Genome Sequencing (WGS) · Whole Exome Sequencing (WES) · RNA Sequencing · Targeted PGx Panels · cfDNA Sequencing · Machine Learning–Assisted Variant Analysis
Why Us?
AUGenomics bridges the gap between sequencing technology and actionable clinical insight. Our team of genomic scientists and method developers brings deep experience in translational and clinical genomics—helping you move from data to decision faster.
We deliver:
-
Tailored PGx workflows for both discovery and validation phases
-
Ultra-fast turnaround—results in as little as 3–5 days for select projects
-
High-quality variant calling and annotation pipelines
-
Integration with bioinformatics and regulatory reporting formats
-
Collaborative consultation with scientific experts in pharmacogenomics and clinical genomics
-
Full transparency and support through our project portal
Our mission is to make personalized medicine practical, scalable, and precise—accelerating your path from discovery to clinical implementation.
Let’s Work Together
Get in touch so we can start working together.
